Brief: Irlab Therapeutics AB Q4 Operating Loss SEK 26.3 MLM

IRLAB Therapeutics AB

06/02/2020 06:48

Feb 6 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB THERAPEUTICS AB - Q4 OPERATING LOSS SEK 26.3 MILLION VERSUS LOSS SEK 18.6 MILLION
YEAR AGO
    * IRLAB THERAPEUTICS AB - BOARD PROPOSES NO DIVIDEND FOR FY 2019

Source text for Eikon:  ID:nWkr381lgG 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))